GlassScriptPhysician profile
Anne Elizabeth Dude
NPI 1083185813
$10,638.93
in general payments reported to CMS, 2019-2025
23 companies · $638 in 2025
The $638 reported for 2025 was more than what 79% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,070 · 2022: $2,900 · 2023: $2,741 · 2024: $3,289 · 2025: $638.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,616 · Travel and Lodging: $1,053.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,615.77 |
| Travel and Lodging | $1,053.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,350.52 | 2021-2025 | Micra, Cobalt Dr Mri Surescan, Mycarelink |
| Atricure, INC. | $1,912.53 | 2022-2024 | |
| Boston Scientific Corporation | $967.96 | 2021-2025 | Watchman Flx, Watchman Access System, Watchman |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $794.92 | 2021-2025 | Lifevest |
| Abbott Laboratories | $739.91 | 2023-2025 | Ensite Precision, Cardiomems, Viewmate |
| Impulse Dynamics (USA) INC. | $584.14 | 2023-2024 | Optimizer, Optimizer |
| Merck Sharp & Dohme LLC | $410.16 | 2022-2025 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $375.79 | 2021-2025 | Camzyos, Eliquis |
| Irhythm Technologies, INC. | $345.61 | 2021-2024 | Zio Xt Patch, Zio Monitor |
| Astrazeneca Pharmaceuticals LP | $275.24 | 2021-2024 | Wainua |
| Novartis Pharmaceuticals Corporation | $161.29 | 2023-2024 | |
| Novo Nordisk INC | $137.19 | 2025 | Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $130.38 | 2024 | Jardiance |
| Amgen INC. | $86.27 | 2023-2025 | Repatha |
| Alnylam Pharmaceuticals INC. | $73.31 | 2023-2024 | Onpattro |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $71.98 | 2022-2023 | Assure Wcd |
| Sanofi-Aventis U.S. LLC | $50.79 | 2021-2023 | |
| Baxter Healthcare | $47.67 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Amarin Pharma, INC. | $42.31 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $35.00 | 2024 | |
| Janssen Pharmaceuticals, INC | $16.29 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.24 | 2023 | |
| Kiniksa Pharmaceuticals International, Plc | $13.43 | 2024 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Dude listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.